HomeCompareVRAR vs NOBL

VRAR vs NOBL: Dividend Comparison 2026

VRAR yields 377.57% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRAR wins by $7521.28M in total portfolio value
10 years
VRAR
VRAR
● Live price
377.57%
Share price
$0.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7521.31M
Annual income
$4,944,975,138.14
Full VRAR calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — VRAR vs NOBL

📍 VRAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRARNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRAR + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRAR pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRAR
Annual income on $10K today (after 15% tax)
$32,093.64/yr
After 10yr DRIP, annual income (after tax)
$4,203,228,867.42/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, VRAR beats the other by $4,203,228,658.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRAR + NOBL for your $10,000?

VRAR: 50%NOBL: 50%
100% NOBL50/50100% VRAR
Portfolio after 10yr
$3760.67M
Annual income
$2,472,487,692.16/yr
Blended yield
65.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VRAR right now

VRAR
Analyst Ratings
3
Buy
Consensus: Buy
Price Target
$12.00
+2165.4% upside vs current
Range: $12.00 — $12.00
Altman Z
-5.6
Piotroski
1/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRAR buys
0
NOBL buys
0
No recent congressional trades found for VRAR or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRARNOBL
Forward yield377.57%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$7521.31M$22.8K
Annual income after 10y$4,944,975,138.14$246.19
Total dividends collected$7280.40M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: VRAR vs NOBL ($10,000, DRIP)

YearVRAR PortfolioVRAR Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$48,457$37,757.22$10,914$214.34+$37.5KVRAR
2$222,841$170,991.59$11,897$218.63+$210.9KVRAR
3$973,338$734,898.24$12,952$222.72+$960.4KVRAR
4$4,041,410$2,999,938.35$14,086$226.62+$4.03MVRAR
5$15,965,510$11,641,201.73$15,302$230.33+$15.95MVRAR
6$60,062,851$42,979,755.42$16,607$233.85+$60.05MVRAR
7$215,380,765$151,113,513.41$18,007$237.18+$215.36MVRAR
8$736,888,664$506,431,246.00$19,508$240.35+$736.87MVRAR
9$2,407,787,131$1,619,316,260.18$21,116$243.35+$2407.77MVRAR
10$7,521,307,368$4,944,975,138.14$22,841$246.19+$7521.28MVRAR

VRAR vs NOBL: Complete Analysis 2026

VRARStock

The Glimpse Group, Inc., a virtual reality (VR) and augmented reality (AR) platform company, provides enterprise-focused software, services, and solutions in the United States. It offers QReal, a software that creates and distributes photorealistic 3D and AR content; Adept XR Learning, which provides higher education learning and corporate VR training solutions; PostReality, a cloud-based software as a service solution that enables users to create AR presentations; and XR Platform, a cloud-based, scalable and secure backend infrastructure, including proprietary cloud image recognition technology, online storage, creation and management of subscription plans, and invoicing and payments designed for VR/AR companies. The company also provides D6 VR, a VR-based, analysis, presentation, and education software platform; Immersive Health Group, a digital health platform that leverages VR/AR technology to simplify and streamline complex healthcare challenges in scale; Foretell Reality, an enterprise-grade and easy-to-use solution for meeting others in VR; and Early Adopter, which offers immersive VR and AR EdTech solutions for K-12 schools and pediatric hospital programs. In addition, it offers AUGGD that provides AR software and services primarily for the architecture, engineering, and construction industries; Glimpse Turkey for developing and creating web optimized 3D models, primarily for QReal; and custom specialized AR applications, and white label solutions and services. Further, the company provides Pagoni VR that offers VR video broadcasting solutions, which consists of Chimera that enables real-time communications between a presenter, and local and remote attendees in VR to universities, enterprise, entertainment venues, sports venues, and houses of worship. The company was incorporated in 2016 and is headquartered in New York, New York.

Full VRAR Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this VRAR vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRAR vs SCHDVRAR vs JEPIVRAR vs OVRAR vs KOVRAR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.